Renal outcomes in diabetic kidney patients treated with GLP1 agonist receptors vs SGLT2 inhibitors

Citation
Maroto A, Marques Vidas M, Sanz I, et al. Nephrol Dial Transpl 2020;35(Suppl 3):gfaa142.P1009